RIPK2 p.Phe90Cys
c.269T>G · rs1374082877 · VCV3154523
Computational evidence
| Protein change | ||
| AlphaMissense | 0.7971 | likely pathogenic |
|---|---|---|
| REVEL | 0.28 | benign-leaning |
| SaProt | LLR -7.64 | tolerated |
| ⇒ AlphaMissense calls this damaging; REVEL and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.9 | GERP 1.4, phastCons 1 |
| Regional constraint | o/e 0.84 | unconstrained · MANE · 32 kb · p 0.00018 · regional, not allelic |
| Overall | ||
| CADD | 27.3 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Middle Easterngrpmax | 0.0172% | 5,808 |
| European (non-Finnish) | 0.00203% | 49,271 |
| Remaining individualsnot grpmax-eligible | 0.00171% | 58,590 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- RIPK2
- Protein
- p.Phe90Cys
- Coding
- c.269T>G
- MANE Select
- NM_003821
- dbSNP
- rs1374082877
- Type
- single nucleotide variant
- Location
- chr8:89762924 (GRCh38)
- Gene constraint
- LOEUF 0.532 · pLI 0.95 (gnomAD)
- Structure
- AlphaFold pLDDT 76.99 · 33 PDB
- Residue 90
- the protein kinase domain
Similar variants
- RIPK2 p.Leu268Val Benign ★★ same type
- RIPK2 p.Ser204= Benign ★★ same type
- RIPK2 p.Ala263Thr Uncertain significance ★ ⚠ same type
- RIPK2 p.Ala405Val Uncertain significance ★ ⚠ same type
- RIPK2 p.Arg123Cys Uncertain significance ★ ⚠ same type
- RIPK2 p.Arg171His Uncertain significance ★ ⚠ same type
- RIPK2 p.Arg264Cys Uncertain significance ★ ⚠ same type
- RIPK2 p.Arg430His Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ripk2-p-phe90cys (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown